NO140628C - Analogifremgangsmaate for fremstilling av nye, terapeutisk virksomme aminer - Google Patents
Analogifremgangsmaate for fremstilling av nye, terapeutisk virksomme aminerInfo
- Publication number
- NO140628C NO140628C NO750468A NO750468A NO140628C NO 140628 C NO140628 C NO 140628C NO 750468 A NO750468 A NO 750468A NO 750468 A NO750468 A NO 750468A NO 140628 C NO140628 C NO 140628C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically effective
- new therapeutically
- analogical procedure
- effective amines
- Prior art date
Links
- 150000001412 amines Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7401958A SE388849B (sv) | 1974-02-14 | 1974-02-14 | Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan |
Publications (3)
Publication Number | Publication Date |
---|---|
NO750468L NO750468L (fr) | 1975-08-15 |
NO140628B NO140628B (no) | 1979-07-02 |
NO140628C true NO140628C (no) | 1979-10-10 |
Family
ID=20320208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO750468A NO140628C (no) | 1974-02-14 | 1975-02-13 | Analogifremgangsmaate for fremstilling av nye, terapeutisk virksomme aminer |
Country Status (23)
Country | Link |
---|---|
US (2) | US4244969A (fr) |
JP (1) | JPS50116433A (fr) |
AT (1) | AT334881B (fr) |
AU (1) | AU497441B2 (fr) |
BE (1) | BE825515A (fr) |
CA (1) | CA1052387A (fr) |
CH (1) | CH616648A5 (fr) |
CS (2) | CS202035B2 (fr) |
DD (1) | DD118614A5 (fr) |
DE (1) | DE2502993A1 (fr) |
DK (1) | DK135711B (fr) |
FI (1) | FI62055B (fr) |
FR (1) | FR2261000B1 (fr) |
GB (1) | GB1492647A (fr) |
HU (1) | HU169704B (fr) |
IE (1) | IE41350B1 (fr) |
IT (1) | IT7950875A0 (fr) |
LU (1) | LU71846A1 (fr) |
NL (1) | NL7501785A (fr) |
NO (1) | NO140628C (fr) |
SE (1) | SE388849B (fr) |
SU (3) | SU603332A3 (fr) |
ZA (1) | ZA75381B (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4210653A (en) * | 1978-06-27 | 1980-07-01 | Merck & Co., Inc. | Pyridyloxypropanolamines |
SE8004088L (sv) | 1980-06-02 | 1981-12-03 | Haessle Ab | Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ... |
US4396629A (en) * | 1980-12-29 | 1983-08-02 | Sterling Drug Inc. | Compositions, processes and method |
CA1262729A (fr) * | 1983-10-19 | 1989-11-07 | Leo Alig | Phenoxypropanolamines |
US5166218A (en) * | 1983-10-19 | 1992-11-24 | Hoffmann-La Roche Inc. | Phenoxypropanolamines and pharmaceutical compositions thereof |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DE3544172A1 (de) * | 1985-12-13 | 1987-06-19 | Lentia Gmbh | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
ES2005525T3 (es) * | 1987-03-26 | 1992-10-01 | Helopharm W. Petrik Gmbh & Co.Kg. | Procedimiento para la fabricacion de 5-hidroxi-diprafenona y sus sales con acidos. |
SG99290A1 (en) * | 1996-04-09 | 2003-10-27 | Nps Pharma Inc | Calcilytic compounds |
US6818660B2 (en) | 1996-04-09 | 2004-11-16 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
US5966498A (en) * | 1996-08-07 | 1999-10-12 | Lakewood Engineering And Manufacturing Company | End closure assembly for oil-filled heater |
TW483881B (en) | 1996-12-03 | 2002-04-21 | Nps Pharma Inc | Calcilytic compounds |
US7202261B2 (en) | 1996-12-03 | 2007-04-10 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
JP4604583B2 (ja) * | 2004-07-20 | 2011-01-05 | ダイソー株式会社 | 1−アミド−3−(2−ヒドロキシフェノキシ)−2−プロパノール誘導体、ならびに2−アミドメチル−1,4−ベンゾジオキサン誘導体の製造法 |
IL165365A0 (en) | 2004-11-24 | 2006-01-15 | Q Core Ltd | Finger-type peristaltic pump |
JP4934287B2 (ja) * | 2005-04-05 | 2012-05-16 | 花王株式会社 | 美白剤 |
FR2916441B1 (fr) * | 2007-05-22 | 2009-08-28 | Clariant Specialty Fine Chem | Procede de racemisation d'alpha-aminoacetals optiquement actifs. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL301580A (fr) * | 1962-12-11 | |||
GB1069345A (en) * | 1963-07-19 | 1967-05-17 | Ici Ltd | New alkanolamine derivatives |
DE1922003C3 (de) * | 1969-04-30 | 1979-10-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz |
BE790165A (fr) * | 1971-12-14 | 1973-02-15 | Parke Davis & Co | Nouveaux aminoalcanols et procede pour les preparer |
-
1974
- 1974-02-14 SE SE7401958A patent/SE388849B/xx unknown
-
1975
- 1975-01-20 ZA ZA00750381A patent/ZA75381B/xx unknown
- 1975-01-25 DE DE19752502993 patent/DE2502993A1/de not_active Ceased
- 1975-02-10 AT AT96475*#A patent/AT334881B/de not_active IP Right Cessation
- 1975-02-12 SU SU752104405A patent/SU603332A3/ru active
- 1975-02-12 DD DD184143A patent/DD118614A5/xx unknown
- 1975-02-12 FI FI750390A patent/FI62055B/fi not_active Application Discontinuation
- 1975-02-12 AU AU78116/75A patent/AU497441B2/en not_active Expired
- 1975-02-12 CH CH169075A patent/CH616648A5/de not_active IP Right Cessation
- 1975-02-13 NO NO750468A patent/NO140628C/no unknown
- 1975-02-13 GB GB6172/75A patent/GB1492647A/en not_active Expired
- 1975-02-13 US US05/549,841 patent/US4244969A/en not_active Expired - Lifetime
- 1975-02-13 HU HUHE678A patent/HU169704B/hu unknown
- 1975-02-13 CA CA220,014A patent/CA1052387A/fr not_active Expired
- 1975-02-13 IE IE279/75A patent/IE41350B1/xx unknown
- 1975-02-13 FR FR7504553A patent/FR2261000B1/fr not_active Expired
- 1975-02-14 JP JP50018088A patent/JPS50116433A/ja active Pending
- 1975-02-14 NL NL7501785A patent/NL7501785A/xx not_active Application Discontinuation
- 1975-02-14 LU LU71846A patent/LU71846A1/xx unknown
- 1975-02-14 CS CS75986A patent/CS202035B2/cs unknown
- 1975-02-14 DK DK53975AA patent/DK135711B/da unknown
- 1975-02-14 BE BE153340A patent/BE825515A/fr unknown
-
1976
- 1976-01-20 SU SU762315654A patent/SU609460A3/ru active
- 1976-01-23 SU SU7602314963A patent/SU577971A3/ru active
-
1978
- 1978-08-28 CS CS785579A patent/CS202036B2/cs unknown
-
1979
- 1979-11-21 IT IT7950875A patent/IT7950875A0/it unknown
-
1980
- 1980-05-19 US US06/150,883 patent/US4336267A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AT334881B (de) | 1977-02-10 |
NO750468L (fr) | 1975-08-15 |
AU7811675A (en) | 1976-08-12 |
ZA75381B (en) | 1976-01-28 |
SU603332A3 (ru) | 1978-04-15 |
BE825515A (fr) | 1975-08-14 |
SE388849B (sv) | 1976-10-18 |
CH616648A5 (fr) | 1980-04-15 |
IE41350L (en) | 1975-08-14 |
ATA96475A (de) | 1976-06-15 |
CS202035B2 (en) | 1980-12-31 |
DK135711C (fr) | 1977-11-21 |
FI750390A (fr) | 1975-08-15 |
DE2502993A1 (de) | 1975-09-04 |
JPS50116433A (fr) | 1975-09-11 |
SE7401958L (fr) | 1975-08-15 |
IE41350B1 (en) | 1979-12-19 |
LU71846A1 (fr) | 1975-12-09 |
SU609460A3 (ru) | 1978-05-30 |
CA1052387A (fr) | 1979-04-10 |
US4336267A (en) | 1982-06-22 |
DK135711B (da) | 1977-06-13 |
IT7950875A0 (it) | 1979-11-21 |
HU169704B (fr) | 1977-02-28 |
CS202036B2 (en) | 1980-12-31 |
DK53975A (fr) | 1975-10-06 |
SU577971A3 (ru) | 1977-10-25 |
FR2261000A1 (fr) | 1975-09-12 |
US4244969A (en) | 1981-01-13 |
NL7501785A (nl) | 1975-08-18 |
FR2261000B1 (fr) | 1978-07-21 |
DD118614A5 (fr) | 1976-03-12 |
AU497441B2 (en) | 1978-12-14 |
FI62055B (fi) | 1982-07-30 |
NO140628B (no) | 1979-07-02 |
GB1492647A (en) | 1977-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1063768B (it) | Procedimento perfezionato per la fabbricazione di dispositivi semiconduttori | |
NO145691C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme decapeptidamider | |
NO157933C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme cefemforbindelser. | |
SE7807571L (sv) | Forfarande for framstellning av antigraviditetsvaccin | |
NO140628C (no) | Analogifremgangsmaate for fremstilling av nye, terapeutisk virksomme aminer | |
NO142709C (no) | Fremgangsmaate til fremstilling av tertiaere alifatiske aminer | |
NO139167C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive aminer | |
RO66457A (fr) | Procede pour la preparation des alcoxy carbonylephenylecarbamides utilisees comme herbicides | |
NO138599C (no) | Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater | |
NO146199C (no) | Fremgangsmaate for fremstilling av alfa-6-deoksy-5-hydroksytetracyklin-hydroklorid | |
NO144773C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive aminer. | |
DK147854C (da) | Analogifremgangsmaade til fremstilling af n-(1-benzylpiperid-4-yl)-benzamider | |
NO140012C (no) | Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin | |
SE403477B (sv) | Forfarande for famstellning av substituerade indoleniner | |
NO146058C (no) | Analogifremgangsmaate for fremstilling av substituerte benzamider | |
SE7607717L (sv) | Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid | |
SE428469B (sv) | Forfarande for framstellning av tertiera aminer. | |
SE404926B (sv) | Analogiforfarande for framstellning av 3-piperazin-isokinoliner | |
NO142218C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme aminderivater | |
NO139733C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin | |
SE414028B (sv) | Forfarande for framstellning av terapeutisk verksamma fentiazinderivat | |
SE426948B (sv) | Analogiforfarande for framstellning av 3-deoxibutirosin a | |
NO138088C (no) | Analogifremgangsmaate til fremstilling av nye terapeutisk virksomme kinazolin-forbindelser | |
SE415656B (sv) | Forfarande for framstellning av aminderivat av azidofenoler. | |
NO139859C (no) | Fremgangsmaate for fremstilling av uretaner ved siden av aminer |